<SEC-DOCUMENT>0001610717-25-000163.txt : 20250605
<SEC-HEADER>0001610717-25-000163.hdr.sgml : 20250605
<ACCEPTANCE-DATETIME>20250605164215
ACCESSION NUMBER:		0001610717-25-000163
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20250605
FILED AS OF DATE:		20250605
DATE AS OF CHANGE:		20250605

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Klapstein Julie D
		CENTRAL INDEX KEY:			0001518668
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42679
		FILM NUMBER:		251027723

	MAIL ADDRESS:	
		STREET 1:		1239 FRUIT COVE ROAD NORTH
		CITY:			JACKSONVILLE
		STATE:			FL
		ZIP:			32259

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Omada Health, Inc.
		CENTRAL INDEX KEY:			0001611115
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HEALTH SERVICES [8000]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				452355015
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		500 SANSOME STREET
		STREET 2:		SUITE 200
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94111
		BUSINESS PHONE:		888-987-8337

	MAIL ADDRESS:	
		STREET 1:		500 SANSOME STREET
		STREET 2:		SUITE 200
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94111
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>form3.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2025-06-05</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001611115</issuerCik>
        <issuerName>Omada Health, Inc.</issuerName>
        <issuerTradingSymbol>OMDA</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001518668</rptOwnerCik>
            <rptOwnerName>Klapstein Julie D</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O OMADA HEALTH, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>500 SANSOME STREET, SUITE 200</rptOwnerStreet2>
            <rptOwnerCity>SAN FRANCISCO</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>94111</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>true</isDirector>
        </reportingOwnerRelationship>
    </reportingOwner>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Stock Option (Right to Buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>8.97</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <value>2034-09-02</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>100000</value>
                    <footnoteId id="F2"/>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">1/48th of the shares subject to the option vest on each monthly anniversary measured from June 28, 2024 (the &quot;Vesting Commencement Date&quot;), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.</footnote>
        <footnote id="F2">Reflects a 1-for-3 reverse stock split of the Issuer's outstanding common stock effected on May 27, 2025.</footnote>
    </footnotes>

    <remarks>Exhibit 24.1 - Power of Attorney</remarks>

    <ownerSignature>
        <signatureName>/s/ Nathan Salha, as Attorney-in-Fact for Julie D. Klapstein</signatureName>
        <signatureDate>2025-06-05</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.1
<SEQUENCE>2
<FILENAME>poa.htm
<DESCRIPTION>POWER OF ATTORNEY
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Latham & Watkins LLP
         Document created using Broadridge PROfile 24.6.1.5240
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div style="text-align: center; font-variant: small-caps; font-weight: bold;">SECTION 16 AND FORM 144<br>
    POWER OF ATTORNEY</div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 36pt;">With respect to holdings of and transactions in securities
      issued by Omada Health, Inc. (the &#8220;<font style="font-weight: bold; font-style: italic;">Company</font>&#8221;),
      the undersigned hereby constitutes and appoints the individuals named on <font style="font-weight: bold;"><u>Schedule A</u></font> attached hereto and as may be amended from time to time, or any of them signing singly, with full power of substitution and resubstitution, to act as the undersigned&#8217;s true and lawful attorney-in-fact to:</div>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" id="z909fe2a5669848cdaea47fb62dffa87c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 63pt; vertical-align: top; text-align: right;">
            <div style="text-align: left; margin-left: 36pt;">1.</div>
          </td>
          <td style="width: auto; vertical-align: top;">
            <div style="text-align: justify;">execute for and on behalf of the undersigned, Schedules 13D and 13G in accordance with Section 13 of the Securities Exchange Act of 1934, as
              amended (the &#8220;<font style="font-weight: bold; font-style: italic;">Exchange Act</font>&#8221;), and the rules thereunder, and Forms 3, 4, and 5 in accordance with Section 16 of the
              Exchange Act and the rules thereunder, and Notices of Proposed Sale of Securities Pursuant to Rule 144 (<font style="font-weight: bold; font-style: italic;">&#8220;Form 144&#8221;</font>), in
              accordance with the requirements of Rule 144 under the Securities Act of 1933, as amended (the &#8220;<font style="font-weight: bold; font-style: italic;">Securities Act</font>&#8221;); and</div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" id="z760208f6041540229571638222f98daf" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 63pt; vertical-align: top; text-align: right;">
            <div style="text-align: left; margin-left: 36pt;">2.</div>
          </td>
          <td style="width: auto; vertical-align: top;">
            <div style="text-align: justify;">do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Schedule
              13D, Schedule 13G, Form 3, Form 4, Form 5, and Form 144, complete and execute any amendment or amendments thereto, and to timely file such Schedule 13D, Schedule 13G, Form 3, Form 4, Form 5, and Form 144, as applicable, and any amendment
              thereto, with the United States Securities and Exchange Commission&#160; and any stock exchange or similar authority.</div>
          </td>
        </tr>

    </table>
  </div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 36pt;">The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing
    whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution and
    resubstitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorneys-in-fact substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers
    herein granted.</div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 36pt;">The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not
    assuming, nor is the Company assuming, any of the undersigned&#8217;s responsibilities to comply with Section 13 and Section 16 of the Exchange Act, or Rule 144 under the Securities Act.</div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 36pt;">This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file any Schedule 13D,
    Schedule 13G, Form 3, Form 4, Form 5, and Form 144 with respect to the undersigned&#8217;s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing
    attorneys-in-fact.</div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 36pt;">IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 26th day of March, 2025.</div>
  <div><br>
  </div>
  <div><br>
  </div>
  <div style="text-align: justify; margin-left: 288pt;"><u>/s/ Julie D. Klapstein</u><font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 12pt">&#160;</font></div>
  <div style="text-align: justify; margin-left: 288pt;">Julie D. Klapstein</div>
  <div><br>
  </div>
  <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div class="BRPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: center;"><u>Schedule A</u></div>
  <div><br>
  </div>
  <div style="text-align: center; font-weight: bold;">INDIVIDUALS APPOINTED AS ATTORNEY-IN-FACT,</div>
  <div style="text-align: center; font-weight: bold;">WITH FULL POWER OF SUBSTITUTION AND RESUBSTITUTION</div>
  <div><br>
  </div>
  <div style="text-align: justify;">1.<font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font>Chief Executive Officer of the Company, who is currently Sean Patrick Duffy</div>
  <div style="text-align: justify;">2.<font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font>Chief Financial Officer of the Company, who is currently Steven Cook</div>
  <div style="text-align: justify;">3.<font class="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font>General Counsel of the Company, who is currently Nathan Salha</div>
  <div><br>
  </div>
  <div><br>
  </div>
  <div><br>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
